Advancement in multifunctional nanoparticles for the effective treatment of cancer
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Nanotechnology has gained wider importance for the treatment of various diseases, including cancer. Multifunctional or theranostic agents are emerging as promising therapeutic paradigms, which provide attractive vehicles for both image and therapeutic agents. Nanosystems are capable of diagnosis, specific targeted drug therapy and monitoring therapeutic response. Due to their well-developed surface nature, nanomolecules are easy to anchor with multifunctional groups. AREAS COVERED: The present review aims to give an extensive account on the progress of multifunctional nanoparticles throughout the blooming research with regards to their clinical application in cancer. This paper discusses graphene, a newly developed multifunctional vehicle in nanotechnology. Furthermore, it focuses on the development of tumor cells, the advantages of novel multifunctional nanoparticles over traditional methods and the use of nanoparticles in cancer therapy. In addition, patents issued by the US office are also included. EXPERT OPINION: Despite numerous advantages, multifunctional nanoparticles are still at an infancy stage. Many great achievements have been attained in this field to date, but many challenges still remain. A problem that limits the use of multifunctional nanoparticles is toxicity. If this toxicity can be overcome then the advancement in nanocomposite material science will be well on the way to a prospective treatment of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558 · cited 1×
“Combination of nanotechnology with oncology is a new field of interdisciplinary research, comprising biology, chemistry, engineering and medicine (designing of materials at nanoscale levels to create products that exhibit novel properties), which have profound impact on disease prevention, diagnosis and their treatmen…”
BackgroundBerger, C., Song, Z., Li, T., Li, X., Ogbazghi, A. Y., Feng, R., Dai, Z., Marchenkov, A. N., Conrad, E. H., First, P. N., et al. (2004) · The Journal of Physical Chemistry B · doi:10.1021/jp040650f · Cited by 3,548 · cited 1×
“Recently, researchers have developed an electrochemical aptasensor for labelfree selective and sensitive detection of cancer cells which can be used for the treatment of cancers [99-101].”
BackgroundWang, Y.-X. J., Hussain, S. M., & Krestin, G. P. (2001) · European Radiology · doi:10.1007/s003300100908 · Cited by 1,381
Multifunctional magnetic nanoparticles for targeted imaging and therapy
MCCARTHY, J., & WEISSLEDER, R. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.014 · Cited by 892 · cited 2×
“This results in enhanced anticancer effects, reduction in systemic toxicity and minimum toxicity to normal cells [10,11].”
BackgroundIn vivo imaging of siRNA delivery and silencing in tumors
Medarova, Z., Pham, W., Farrar, C., Petkova, V., & Moore, A. (2007) · Nature Medicine · doi:10.1038/nm1486 · Cited by 697
Cited by
Punetha, V. D., Rana, S., Yoo, H. J., Chaurasia, A., McLeskey, J. T., Ramasamy, M. S., Sahoo, N. G., & Cho, J. W. (2017) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2016.12.010 · Cited by 656
Behavior and Toxicity of Graphene and Its Functionalized Derivatives in Biological Systems
Yang, K., Li, Y., Tan, X., Peng, R., & Liu, Z. (2013) · Small · doi:10.1002/smll.201201417 · Cited by 462
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
Kashyap, D., Tuli, H. S., Yerer, M. B., Sharma, A., Sak, K., Srivastava, S., Pandey, A., Garg, V. K., Sethi, G., & Bishayee, A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.014 · Cited by 390
Ginger and its active compounds in cancer therapy: From folk uses to nano-therapeutic applications
Mahomoodally, M. F., Aumeeruddy, M. Z., Rengasamy, K. R. R., Roshan, S., Hammad, S., Pandohee, J., Hu, X., & Zengin, G. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.009 · Cited by 178
Extracellular vesicles in cancer nanomedicine
Tarasov, V. V., Svistunov, A. A., Chubarev, V. N., Dostdar, S. A., Sokolov, A. V., Brzecka, A., Sukocheva, O., Neganova, M. E., Klochkov, S. G., Somasundaram, S. G., et al. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.017 · Cited by 97
Metadata
- Authors
- Rahman, M., Ahmad, M. Z., Kazmi, I., Akhter, S., Afzal, M., Gupta, G., Jalees Ahmed, F., & Anwar, F.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa Healthcare
- Published
- 2012-03-08
- Volume
- 9
- Issue
- 4
- Pages
- 367-381
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W1982936928
- Cited by
- 97
- References
- 5
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Advancement in multifunctional nanoparticles for the effective treatment of cancer. https://app.cochat.ai/papers/10.1517/17425247.2012.668522
- The paper
- Rahman, M., Ahmad, M. Z., Kazmi, I., Akhter, S., Afzal, M., Gupta, G., Jalees Ahmed, F., & Anwar, F. (2012). Advancement in multifunctional nanoparticles for the effective treatment of cancer. Expert Opinion on Drug Delivery. https://doi.org/10.1517/17425247.2012.668522
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.